China’s CanSino Covid vaccine efficacy in Pakistan almost 75%: PM's aide
Special Assistant to the Prime Minister (SAPM) on Health Dr Faisal Sultan on Monday said that CanSino Biologics Inc’s coronavirus shot has an efficacy rate of 65.7% at preventing symptomatic cases based on multi-country analysis, making it the latest vaccine candidate to show protection against COVID-19
Special Assistant to the Prime Minister (SAPM) on Health Dr Faisal Sultan on Monday said that CanSino Biologics Inc’s coronavirus shot has an efficacy rate of 65.7% at preventing symptomatic cases based on multi-country analysis, making it the latest vaccine candidate to show protection against COVID-19.
He said that the interim analysis by the Independent Data Monitoring Committee showed 90.98% efficacy at preventing severe disease.
"Clinical trial data (phase-3) of a one-dose Ad5-nCoV vaccine for Covid (Cansino Bio) received. Interim analysis by the Independent Data Monitoring Committee shows 65.7% efficacy at preventing symptomatic cases and 90.98% at preventing severe disease (multicountry analysis)," the SAPM said in a tweet from his official handle.
Post a Comment